MBX Biosciences, Inc. MBX Total Liabilities
Total Liabilities at other companies
Other financials
Where this comes from
Reported directly by MBX Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Liabilities.
The official record: MBX Biosciences, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about MBX Biosciences, Inc.'s total liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is MBX Biosciences, Inc.'s total liabilities?
- MBX Biosciences, Inc. (MBX) reported total liabilities of $14.95M in Q1 2026.
- How has MBX Biosciences, Inc.'s total liabilities changed year-over-year?
- MBX Biosciences, Inc.'s total liabilities increased by 42.3% year-over-year, from $10.5M to $14.95M.
- What is the long-term trend for MBX Biosciences, Inc.'s total liabilities?
- Over 2 years (2023 to 2025), MBX Biosciences, Inc.'s total liabilities has grown at a 92.6% compound annual growth rate (CAGR), from $4.29M to $15.92M.
- What does total liabilities mean?
- The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.